Regencell Bioscience Holdings Limited
RGC
Kedudukan dalam Saham
#3376
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Harga Saham
$10.41
Modal Pasaran
$5.16B
Perubahan (1 hari)
3.56%
Perubahan (1 tahun)
-38.63%
Negara
HK
Perdagangan Regencell Bioscience Holdings Limited (RGC)
Kategori
Healthcare
Nisbah P/S bagi Regencell Bioscience Holdings Limited (RGC)
Nisbah P/S pada October 2026 TTM: 0.00
Menurut laporan kewangan dan harga saham terkini Regencell Bioscience Holdings Limited, nisbah P/S semasa (TTM) ialah 0.00. Pada akhir 2024, nisbah P/S syarikat ialah 0.00.
Sejarah nisbah P/S untuk Regencell Bioscience Holdings Limited dari 2019 hingga 2026
Nisbah P/S pada akhir setiap tahun
| Tahun | Nisbah P/S | Ubah |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | 0.00% |
| 2021 | 0.00 | 0.00% |
| 2020 | 0.00 | 0.00% |
| 2019 | 0.00 | 0.00% |
Nisbah P/S untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/S | Perbezaan Nisbah P/S | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | - |
IN
|
